Monitoring and Evaluating Medicaid Fee-for-Service Care Management Programs - Appendix 3

Congressional Budget Office. An analysis of the literature on disease management programs. Washington, DC: Government Printing Office; 2004.

Crippen DL. Disease management in Medicare: Data analysis and benefit design issues. Congressional Budget Office Testimony; Statement before the Special Committee on Aging; United States Senate; Sept 19, 2002.

Outcomes guideline report. Washington, DC: Disease Management Association of America; 2006 Dec.

Duncan I. Accuracy in the assessment of return on investment of defined population interventions. Chicago, IL: Jt Comm J Qual Patient Saf 2005;31(6):357.

Duncan I. Evaluating Disease management savings outcomes. Schaumburg, IL: Society of Actuaries; Oct 2005.

Linden A, Roberts N. A users guide to the disease management literature: Recommendations for reporting and assessing program outcomes. Am J Manag Care 2005;11(2):81-90.

MacDowell M, Wilson T. Framework for assessing causality in disease management programs. Washington, DC: Disease Management Association of America; 2003.

Rosenman M, Holmes A, Ackermann R, et al. The Indiana Chronic Disease Management Program. Milbank Q 2006;84(1):135-63.

Volpel A, O'Brien J, Weiner J. Strategies for assessing health plan performance on chronic diseases: Selecting performance indicators and applying health-based risk adjustment. Hamilton, NJ: Center for Health Care Strategies; March 2005.

Williams C. Medicaid disease management: issues and promises. Kaiser Commission on Medicaid and the Uninsured. Washington, DC: Kaiser Family Foundation, Sept 2004.

Wilson T, Thar W, Gruen J, et al. Assessing ROI of defined-population disease management interventions. Jt Comm J Qual Patient Saf 2004;30(11):614-21.

Wilson, T.W. Evaluating ROI in State disease management programs. State Coverage Initiatives Issue Brief. Washington, DC: AcademyHealth, Nov 2003.

Wilson T, Thar W, Gruen J. Reply. Jt Comm J Qual Patient Saf 2005;31(6):358.

Return to Contents